Skip to content

Legal status · United Kingdom

Is Idebenone legal in the United Kingdom?

Written by Reviewed Sep 2026

Not approvedAntioxidantStudies in people cited: 5

Direct answer

No. Idebenone is not an approved medicine in the United Kingdom. Its legal category is "Prescription medicine in the European Union (Raxone)". Nothing that contains it is allowed for any use in people. Vials labeled "for research use only" get no exception: that label does not make them legal to use in people. On the evidence, 5 completed human trials are cited on its profile.

People given it
732
Found nothing
2

Legal category

Prescription medicine in the European Union (Raxone)

Raxone was approved for sale in the EU in September 2015, under exceptional circumstances, for Leber hereditary optic neuropathy. We did not check whether it is currently licensed in Great Britain.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

Idebenone in the United Kingdom at a glance

Legal categoryPrescription medicine in the European Union (Raxone)
NoteRaxone was approved for sale in the EU in September 2015, under exceptional circumstances, for Leber hereditary optic neuropathy. We did not check whether it is currently licensed in Great Britain.
MHRA approval statusNot approved by MHRA
Studies in people5 of 6 sources on the profile
ReviewedSep 2026

The legal category and note come from the Idebenone profile. We checked them against Medicines and Healthcare products Regulatory Agency (MHRA) listings on the reviewed date.

What this means

  • 01

    No product containing Idebenone is approved by MHRA for any use in the United Kingdom. So nothing on sale is allowed for use in people.

  • 02

    "Research use only" is a label sellers put on. It is not a legal category that allows use in people, and it does not get a product out of medicines law.

  • 03

    Importing it, supplying it or promoting it for use in people can fall under medicines law in the United Kingdom. This page is general information, not legal advice.

What Idebenone is

Approved in the European Union for one rare inherited eye disease that causes sudden vision loss. The approval came under special rules because the normal evidence bar was not met. The study behind it missed its main goal, and the studies in Alzheimer's disease and Friedreich ataxia found no benefit.

Idebenone is three separate products wearing one name. They should not be read as backing each other up.

How it works: Idebenone is a small, lab-made cousin of CoQ10. It can take electrons from an enzyme called NQO1 and hand them straight to a later step in the cell's energy chain, skipping a broken first step called complex I.

Approval history: Not FDA approved for any use. Approved in the European Union as Raxone since September 2015, under exceptional circumstances, a special route used when a disease is too rare to collect full data. It treats Leber hereditary optic neuropathy, an inherited disease that causes sudden vision loss. It is also sold in skin care and in brain-boosting supplements. Neither of those is an approved use.

How MHRA treats this kind of product

Licenses medicines for sale in the UK. A compound without a licence to be sold (a marketing authorisation) is an unlicensed medicine. The law only lets it reach people through a prescriber, under the specials scheme (unlicensed medicines made for one patient's needs). It cannot be sold as a research product.

The legal category above is how The Longevity Archive reads Medicines and Healthcare products Regulatory Agency listings for Idebenone on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check MHRA directly

Idebenone in sport and the military

Whether Idebenone is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United Kingdom. Before you compete or get tested, look up Idebenone by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

Idebenone in other countries

Frequently asked questions

Is Idebenone legal in the United Kingdom?

No. Idebenone is not an approved medicine in the United Kingdom. Its legal category is "Prescription medicine in the European Union (Raxone)". Nothing that contains it is allowed for any use in people. Vials labeled "for research use only" get no exception: that label does not make them legal to use in people. On the evidence, 5 completed human trials are cited on its profile. Note: Raxone was approved for sale in the EU in September 2015, under exceptional circumstances, for Leber hereditary optic neuropathy. We did not check whether it is currently licensed in Great Britain.

Can I buy Idebenone in the United Kingdom?

There is no approved product to buy. In the United Kingdom, Idebenone has the legal category "Prescription medicine in the European Union (Raxone)". So no licensed pharmacy product exists. Sellers who list it "for research use only" are not selling it for use in people, and that label does not change its legal status. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything. Note: Raxone was approved for sale in the EU in September 2015, under exceptional circumstances, for Leber hereditary optic neuropathy. We did not check whether it is currently licensed in Great Britain.

Is Idebenone MHRA approved?

No. In the United Kingdom, Idebenone has the legal category "Prescription medicine in the European Union (Raxone)". That is not a MHRA approval to sell it. For comparison, its US FDA status is: Not FDA approved for any use. Approved in the European Union as Raxone since September 2015, under exceptional circumstances, a special route used when a disease is too rare to collect full data. It treats Leber hereditary optic neuropathy, an inherited disease that causes sudden vision loss. It is also sold in skin care and in brain-boosting supplements. Neither of those is an approved use.. On the evidence, 5 completed human trials are cited on its profile.

Related compounds in the United Kingdom

Full research profile

How Idebenone works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

Idebenone profile

This page is general information about the legal status of Idebenone in the United Kingdom, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with Medicines and Healthcare products Regulatory Agency or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.